Your browser doesn't support javascript.
loading
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet.
Monteiro, Cecilia; Toth, Balazs; Brunstein, Flavia; Bobbala, Ashwini; Datta, Seema; Ceniceros, Ryan; Sanabria Bohorquez, Sandra M; Anania, Veronica G; Wildsmith, Kristin R; Schauer, Stephen P; Lee, Julie; Dolton, Michael J; Ramakrishnan, Vidya; Abramzon, Daniel; Teng, Edmond.
Afiliação
  • Monteiro C; From Genentech, Inc., South San Francisco, CA. monteic5@gene.com.
  • Toth B; From Genentech, Inc., South San Francisco, CA.
  • Brunstein F; From Genentech, Inc., South San Francisco, CA.
  • Bobbala A; From Genentech, Inc., South San Francisco, CA.
  • Datta S; From Genentech, Inc., South San Francisco, CA.
  • Ceniceros R; From Genentech, Inc., South San Francisco, CA.
  • Sanabria Bohorquez SM; From Genentech, Inc., South San Francisco, CA.
  • Anania VG; From Genentech, Inc., South San Francisco, CA.
  • Wildsmith KR; From Genentech, Inc., South San Francisco, CA.
  • Schauer SP; From Genentech, Inc., South San Francisco, CA.
  • Lee J; From Genentech, Inc., South San Francisco, CA.
  • Dolton MJ; From Genentech, Inc., South San Francisco, CA.
  • Ramakrishnan V; From Genentech, Inc., South San Francisco, CA.
  • Abramzon D; From Genentech, Inc., South San Francisco, CA.
  • Teng E; From Genentech, Inc., South San Francisco, CA.
Neurology ; 101(14): e1391-e1401, 2023 10 03.
Article em En | MEDLINE | ID: mdl-37643887

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article